Question

the crispr - cas9 system, a revolutionary gene - editing technology, has been employed to target the bcl11a gene, which plays a crucial role in the regulation of fetal hemoglobin production. by disrupting this gene in hematopoietic stem cells, researchers aim to reactivate the production of fetal hemoglobin in patients with sickle cell disease and beta - thalassemia, an approach many believe could potentially alleviate the symptoms of these genetic disorders by compensating for the defective adult hemoglobin. clinical trials have shown promising results, with patients exhibiting increased levels of fetal hemoglobin and a reduction in disease - related complications.
2
what is the main purpose of the text?
a to explain the mechanism by which fetal hemoglobin production is regulated in the human body.
b to highlight the challenges faced in the clinical application of crispr - cas9 technology.
c to compare the effectiveness of different gene - editing techniques in medical research.
d to discuss the potential of a gene - editing technology in treating specific genetic disorders.

Explanation:

The text focuses on how the CRISPR-Cas9 gene-editing system is used to target the BCL11A gene to reactivate fetal hemoglobin, with the goal of alleviating symptoms of sickle cell disease and beta-thalassemia, and notes promising clinical trial results. It centers on the technology's potential for treating these specific genetic disorders, which matches option D. Option A is incorrect as the text does not focus on explaining the regulation mechanism itself. Option B is wrong because no clinical challenges are highlighted. Option C is incorrect as no comparison of different gene-editing techniques is made.

Answer:

D. To discuss the potential of a gene-editing technology in treating specific genetic disorders.